Parkinson’s UK invests a further £490k in NRG Therapeutics to Progress Parkinson’s Drug Discovery Programme

NRG Therapeutics Ltd (“NRG” or “company”), an innovative…

Parkinson’s UK continues drug discovery with NRG Therapeutics Ltd

Parkinson's UK has invested an additional £1 million in NRG…

Dr Richard Seabrook joins Board of NRG Therapeutics

Richard brings over 25 years of experience in scientific translation…